Clinical Research Directory
Browse clinical research sites, groups, and studies.
Splicing-based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer
Sponsor: City of Hope Medical Center
Summary
Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. Although adjuvant chemotherapy improves survival after curative resection, its efficacy varies widely among patients. The absence of reliable predictive biomarkers often leads to overtreatment or undertreatment. This study aims to develop a machine learning-based predictive model for adjuvant chemotherapy response using tumor-derived alternative splicing signatures. By integrating RNA-seq data, splicing isoform and clinical outcomes, this study seeks to identify molecular predictors of treatment response and recurrence risk after surgery.
Official title: Splicing-Based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer (SPLICE)
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2024-06-21
Completion Date
2026-06-18
Last Updated
2025-11-10
Healthy Volunteers
No
Conditions
Interventions
SPLICE
A panel of RNA splicing isoform, whose level is tested in tissue samples derived from the primary tumor.
Locations (1)
City of Hope Medical Center
Duarte, California, United States